CPHI Online is the largest global marketplace in the pharma ingredients industry
2021 CPHI Pharma Awards winners announced
Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.
The world’s largest pharmaceutical exhibition, CPHI Worldwide has announced the winners of the 18th edition of the CPHI Pharma Awards across 10 distinct categories and hosted live at the in-person event in Milan.
CPHI Worldwide represents every stage of the pharmaceutical supply chain - from ingredients and FDF, to machinery, packaging, outsourcing and biopharmaceuticals.
The Awards seek to recognise ‘Excellence in Pharma’, assessing entries from the industry’s leading companies and individuals.
“Despite the challenges of the past 18+ months, the pharmaceutical industry has shown both incredible resilience and a continued pursuit of innovation, something which is clearly reflected in the extremely high standard of entries for this year’s CPHI Pharma Awards,” said Tara Dougal, Head of Content & Insights, Informa Markets. “I’d like to thank our sponsor, Rentschler Biopharma and especially our jury, who lent their time and expertise to assessing the many entries we received. Lastly, I’d like to extend congratulations to all the nominees for their achievements, and of course to this year’s winners!”
Category: CEO of the Year Award
WINNER: Lynne Ann du Toit from Eurolab for her clear vision on what the future of cancer treatment in South Africa should look like. The CPHI judges selected Lynne Ann du Toit in light of her bold, forward-looking leadership.
Category: Packaging & Drug Delivery
WINNER: Eitan Medical for its pre-filled and pre-loaded wearable drug delivery platform. The device is designed for easy, efficient, self-administered subcutaneous delivery of large volumes and high viscosity medications for use in homecare environments.
Category: Supply Chain, Logistics, and Distribution
WINNER: Rephine Sourcing for successfully developing a powerful Supplier Compliance Management Software. The “Rephine Catena” turns supplier qualification and daily supplier data updating into a proactive process worldwide, for the entire supply chain.
WINNER: Adalvo for its strong commitment to the community, having undertaken several notable actions in the last year.
Category: Innovation in Response to Covid-19
WINNER: Novavax, in recognition of its impressive speed of committing to 1.1 billion vaccine doses of COVAX, which has a direct impact on global recovery from the pandemic.
Category: Finished Formulation
WINNER: Clarus Therapeutics for its first-in-class therapeutic advances in addressing unmet medical needs through the development of androgen and metabolic therapies.
Category: API Development
WINNER: Catalent excelled for its programme to boost biological drug development with significant proven output.
Category: Digital Innovation
WINNER: Viatris for developing its real-world evidence methodology for regulatory purposes in noncommunicable diseases, artificial intelligence, machine learning and deep learning.
Category: Regulatory Procedures and Compliance
WINNER: BASF for RegXcellence®, which provides customers with easy-to-use quality and regulatory services, untangling the complexity of providing compliance documentation in support of new and existing pharmaceutical products.
Category: Manufacturing Technology and Equipment
WINNER: Aprecia Pharmaceuticals for its latest transformative technology – the In-Cavity Powder Liquid 3D Printing solution.
About the CPHI Pharma Awards:
Started in 2003, the CPHI Pharma Awards have been committed to recognising excellence in pharma. Over 500 attendees which consist of prominent industry figures come from all around the world to attend this prestigious event.
For more information on the CPHI Pharma Awards please visit: awards.cphi.com
Through a collaboration with biotech company Touchlight, Lonza is set to expand their end-to-end offering for mRNA manufacturing with additional DNA raw material sources, including Touchlight’s doggybone DNA.
The malaria vaccine R21/Matrix-M, developed by researchers at Oxford University, has produced encouraging new data for the global effort against the mosquito-borne disease.
Biopharmaceutical company Takeda and CDMO NextPharma have announced an acquisition agreement in which Takeda will divest from their Asker, Norway manufacturing site, set to be acquired by NextPharma.
The European Medicines Agency has backed the Nuvaxovid COVID-19 vaccine for adults as a booster shot to other COVID-19 vaccines.
The pharmaceutical companies behind the leading COVID-19 vaccines are in a legal dispute over intellectual property rights surrounding the mRNA vaccines that were released after emergency use authorization in December 2020.
With the rapid development and manufacturing of new drugs and therapeutics being pushed through the pipeline, excipient manufacturers are navigating a challenging landscape to meet the demand for new and novel excipients.
News ChargePoint Technology acquires PuroVaso for greater range of powder and liquid transfer solutionsChargePoint Technology has acquired PuroVaso, leader in the design, development, and manufacture of single-use containers, handling equipment, and accessories for pharma, biopharma, and life sciences.
Lonza expands solid-state characterisation services for polymorph and solid-state properties of APIs with the addition of X-ray powder diffraction to its portfolio.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
Generate high-quality, engaged leads for your business, all year round
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
Your company’s profile boosted at all participating CPHI events
An easy-to-use platform with a detailed dashboard showing your leads and performance